Correlation Between GlaxoSmithKline PLC and Advisors Inner

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and Advisors Inner at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and Advisors Inner into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and The Advisors Inner, you can compare the effects of market volatilities on GlaxoSmithKline PLC and Advisors Inner and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of Advisors Inner. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and Advisors Inner.

Diversification Opportunities for GlaxoSmithKline PLC and Advisors Inner

-0.73
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between GlaxoSmithKline and Advisors is -0.73. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and The Advisors Inner in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Advisors Inner and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with Advisors Inner. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Advisors Inner has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and Advisors Inner go up and down completely randomly.

Pair Corralation between GlaxoSmithKline PLC and Advisors Inner

Considering the 90-day investment horizon GlaxoSmithKline PLC is expected to generate 8.88 times less return on investment than Advisors Inner. In addition to that, GlaxoSmithKline PLC is 2.1 times more volatile than The Advisors Inner. It trades about 0.01 of its total potential returns per unit of risk. The Advisors Inner is currently generating about 0.11 per unit of volatility. If you would invest  2,409  in The Advisors Inner on August 28, 2024 and sell it today you would earn a total of  305.00  from holding The Advisors Inner or generate 12.66% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy37.1%
ValuesDaily Returns

GlaxoSmithKline PLC ADR  vs.  The Advisors Inner

 Performance 
       Timeline  
GlaxoSmithKline PLC ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GlaxoSmithKline PLC ADR has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Advisors Inner 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in The Advisors Inner are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Even with relatively invariable basic indicators, Advisors Inner is not utilizing all of its potentials. The recent stock price agitation, may contribute to short-term losses for the retail investors.

GlaxoSmithKline PLC and Advisors Inner Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GlaxoSmithKline PLC and Advisors Inner

The main advantage of trading using opposite GlaxoSmithKline PLC and Advisors Inner positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, Advisors Inner can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Advisors Inner will offset losses from the drop in Advisors Inner's long position.
The idea behind GlaxoSmithKline PLC ADR and The Advisors Inner pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Other Complementary Tools

Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Bonds Directory
Find actively traded corporate debentures issued by US companies